Acting via AMPK regulation, FGF21 protects against atrophy-induced inflammation, and its deficiency induces inflammation and worsens the obesity-induced atrophy of skeletal muscle [62]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.